NCT04329728 2026-04-15
OPAL
AVM Biotechnology Inc
Phase 1/2 Recruiting
AVM Biotechnology Inc
Gyala Therapeutics
Memorial Sloan Kettering Cancer Center
Indiana University
Children's Hospital of Philadelphia
French Innovative Leukemia Organisation
Essen Biotech